ARCHIVES

DCE Board Recompetition Concepts

This article is from The Cancer Letter archive.

Vol. 13 No. 29 | July 17, 1987

Download PDF Visit The Full Archive

Related Articles

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

ELM Wins ACCC Management Contract Over ORC, Others

February 21, 1992

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Funding Opportunities: NCI Schedules Meeting on RFA For Pathology Informatics

May 12, 2000

ASCO Members asked To Help In Planning

August 26, 1988